Clinical trial for Schizophrenia
Official title App and Body Fat Scale in the Management of Overweight Patients
ClinicalTrials.gov ID: NCT05866107
What this study is testing
- What it's testing
- The study wants to see if using the app and scale for 4 months leads to more weight loss than 2 months, and if frequent tracking of weight, diet, and exercise helps people lose more weight. It also looks at whether seeing weight loss results keeps people using the tools.
- Who it's for
- It is looking for adults who are overweight or obese and have schizophrenia or bipolar disorder.
- What's involved
- Participants will weigh themselves weekly with a smart scale that syncs to the Huawei Health app, log their food in the app, and receive personalized diet and exercise tips. Doctors and nutritionists will send supportive messages.
- Time commitment
- The study lasts 4 months and requires weekly weigh‑ins, regular food logging, and ongoing use of the app and scale.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60
You may be able to join if
- Age 18-60 years old, no gender restriction.
- According to ICD-10 to diagnose bipolar disorder or schizophrenia, the researcher judges that the patient is currently in remission, or the condition...
- Currently using at least one antipsychotic or mood stabilizer (e.g. lithium, magnesium valproate, sodium valproate, lamotrigine).
- Currently overweight or obese (body mass index ≥ 24kg/m2) and willing to use health app and smart scales to lose weight.
- The education level of primary school or above, able to understand the content of the scale, and be able to use smart phone proficiently.
You likely can't join if
- Plan to lose weight by other methods during the study period (such as dieting, inducing vomiting, taking diet pills, surgery).
- Self-reported weight loss ≥ 7% in the past 6 months.
- Weight over 150 kg.
- Other secondary obesity (such as hypothyroidism, Cushing's syndrome, hypothalamic obesity, etc.).
- Currently pregnant, lactating, \< 6 months postpartum or planning to become pregnant during the study period.
- Self-reported cardiac discomfort or chest pain during activity or at rest.
See the full eligibility criteria
- Age 18-60 years old, no gender restriction.
- According to ICD-10 to diagnose bipolar disorder or schizophrenia, the researcher judges that the patient is currently in remission, or the condition is stable and can cooperate with the research.
- Currently using at least one antipsychotic or mood stabilizer (e.g. lithium, magnesium valproate, sodium valproate, lamotrigine).
- Currently overweight or obese (body mass index ≥ 24kg/m2) and willing to use health app and smart scales to lose weight.
- The education level of primary school or above, able to understand the content of the scale, and be able to use smart phone proficiently.
- Understand and voluntarily participate in this study, and sign the informed consent form.
- Plan to lose weight by other methods during the study period (such as dieting, inducing vomiting, taking diet pills, surgery).
- Self-reported weight loss ≥ 7% in the past 6 months.
- Weight over 150 kg.
- Other secondary obesity (such as hypothyroidism, Cushing's syndrome, hypothalamic obesity, etc.).
- Currently pregnant, lactating, \< 6 months postpartum or planning to become pregnant during the study period.
- Self-reported cardiac discomfort or chest pain during activity or at rest.
- There is a serious medical condition, and the researchers believe that there may be safety risks when participating in sports.
- Be unable to walk 30 minutes without stopping.
- There are problems that may affect compliance with the protocol (eg, end-stage disease, planning to move travel to the field, history of substance abuse, other uncontrolled or untreated medical conditions);
- Any other conditions deemed inappropriate by the investigator. Participants include approximately 50% with schizophrenia and 50% with bipolar disorder, distributed across all clusters.
The study team makes the final eligibility decision.
Where it is enrolling
- Beijing, Beijing Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Beijing, Beijing Municipality, China. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.